Your session is about to expire
← Back to Search
Digital Communication Tool for Post-Hospitalization Care in Older Adults (DB Trial)
N/A
Recruiting
Led By Carolyn Steele Gray, PhD
Research Sponsored by Mount Sinai Hospital, Canada
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients aged 60 and over, with CCN defined as presenting with 3 or more chronic conditions from the 16 most prominent in the population, which is an established method to identifying patients with CCN.
Be older than 18 years old
Must not have
Died in hospital.
Discharge destination is another acute care facility, palliative care unit, complex continuing care, or long term care.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 1-2weeks, 3 and 6 months post-discharge
Awards & highlights
No Placebo-Only Group
Summary
This trial will develop and test a "Digital Bridge" to improve communication between hospital and primary care providers, patients, and their caregivers. The goal is to reduce risk of readmission and improve patient experience and outcomes.
Who is the study for?
This trial is for older adults aged 60 and over with complex care needs, defined as having three or more chronic conditions. Participants must speak and read English, be able to respond to surveys, have family or caregivers available if needed, and plan to go home after hospital discharge.
What is being tested?
The Digital Bridge tool intervention is being tested. It aims to improve communication between healthcare providers in hospitals and primary care settings, patients, and their families from admission until six months after leaving the hospital.
What are the potential side effects?
Since this trial involves a digital communication tool rather than medication or medical procedures, traditional side effects are not applicable. However, participants may experience issues related to technology use such as privacy concerns or stress due to technical difficulties.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 60 or older with 3 or more long-term health conditions.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
Not applicable as the patient has passed away.
Select...
I will be moved to another care facility or a long-term care after discharge.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at 1-2 weeks post-discharge
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 1-2 weeks post-discharge
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Care Transitions Measure (CTM3)
Secondary study objectives
Assessment for Quality of Life Scale 4D -AQoL-4D
Caregiver information sheet
Patient information sheet
+3 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: (Digital Bridge intervention)Experimental Treatment1 Intervention
Experimental (Digital Bridge intervention) participants will complete surveys at 4 time points (baseline, 1-2 weeks, 3 month and 6 months after discharge). The surveys will capture data on demographics, assess their transition quality, self-reported costs, assess their quality of life, and goal attainment.
One to two days before discharge, patients will work with their team to develop the PODS in Care Connector. Once the PODS is created, the patient and hospital provider will be prompted to set transition goals using the ePRO tool.
Group II: ControlActive Control1 Intervention
Control: Control participants will complete surveys at 4 time points (baseline, 1-2 weeks, 3 month and 6 months after discharge). The surveys will capture data on demographics, assess their transition quality, self-reported costs, and assess their quality of life. Aside from completion of these surveys, no changes to their usual care will occur.
Find a Location
Who is running the clinical trial?
Mount Sinai Hospital, CanadaLead Sponsor
204 Previous Clinical Trials
68,557 Total Patients Enrolled
MOUNT SINAI HOSPITALOTHER
42 Previous Clinical Trials
16,344 Total Patients Enrolled
Trillium Health PartnersOTHER
7 Previous Clinical Trials
2,449 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,394 Previous Clinical Trials
26,527,218 Total Patients Enrolled
Carolyn Steele Gray, PhDPrincipal InvestigatorSinai Health System
1 Previous Clinical Trials
45 Total Patients Enrolled
Terence Tang, MDPrincipal InvestigatorTrillium Health
1 Previous Clinical Trials
240 Total Patients Enrolled
Michelle Nelson, PhDPrincipal InvestigatorSinai Health System
1 Previous Clinical Trials
108 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 60 or older with 3 or more long-term health conditions.Not applicable as the patient has passed away.I do not have family or caregivers to help me.I will be moved to another care facility or a long-term care after discharge.
Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: (Digital Bridge intervention)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.